{
  "id": "multiple-myeloma-by-provider",
  "display_name": "Multiple Myeloma by Provider",
  "cohort": "Multiple Myeloma, RRMM, by Provider Regimen Selection (2024–2025)",
  "insight_type": "Provider-Specific Margin Analysis",
  "summary": "High variability in provider selection of high-margin regimens. Dr. Thompson uses Dara-based regimens in only 18% of eligible patients vs. practice average of 34%.",
  "chart": {
    "type": "bar",
    "unit": "provider",
    "data": [
      { "name": "Dr. Anderson", "value": 58, "gap": 24, "highlight": false },
      { "name": "Dr. Kumar", "value": 47, "gap": 13, "highlight": false },
      { "name": "Dr. Orlowski", "value": 42, "gap": 8, "highlight": false },
      { "name": "Dr. Shah", "value": 26, "gap": -8, "highlight": false },
      { "name": "Dr. Thompson", "value": 18, "gap": -16, "highlight": true },
      { "name": "Dr. Richardson", "value": 11, "gap": -23, "highlight": true }
    ],
    "benchmark": 34,
    "nccn_target": 40
  },
  "financial_impact": {
    "annual_opportunity": "$225,000/year",
    "math": "$225,000/year = 16% utilization gap × 19 patients × $73,000 margin difference"
  },
  "clinical_impact": {
    "description": "Standardizing regimen selection across providers could improve patient outcomes.",
    "metrics": [
      {
        "type": "PFS",
        "value": "+18.4 months",
        "description": "Potential PFS improvement with optimized regimen selection"
      },
      {
        "type": "OS",
        "value": "+13.3 months",
        "description": "Potential OS improvement"
      },
      {
        "type": "ORR",
        "value": "+31%",
        "description": "Higher response rates with Dara-based regimens"
      },
      {
        "type": "DoT",
        "value": "+42%",
        "description": "Longer duration of therapy"
      },
      {
        "type": "QoL",
        "value": "+22%",
        "description": "Improved quality of life scores"
      }
    ],
    "quantitative": "+18.4 months PFS"
  },
  "peer_comparison": {
    "description": "Top RRMM providers use Dara-based regimens in 55% of eligible patients vs. your practice average of 34%. Dr. Anderson's selection patterns align with top performers.",
    "peer_benchmark": 55,
    "financial_impact": {
      "annual_opportunity": "$450,000/year",
      "math": "$450,000/year = 21% increase × 29 patients × $73,000 margin difference"
    },
    "action_steps": [
      {
        "text": "Schedule peer-to-peer learning between Dr. Thompson and Dr. Anderson",
        "icon": "users"
      },
      {
        "text": "Implement provider-specific regimen selection dashboards",
        "icon": "chart"
      },
      {
        "text": "Create automated decision support tools in EHR",
        "icon": "alert"
      },
      {
        "text": "Develop RRMM case review process for non-Dara regimen selections",
        "icon": "clipboard"
      }
    ]
  },
  "weighted_score": 89,
  "action_steps": [
    {
      "text": "Create provider-specific reports on regimen selection patterns",
      "icon": "chart"
    },
    {
      "text": "Implement educational intervention for Dr. Thompson and Dr. Richardson",
      "icon": "users"
    },
    {
      "text": "Develop standardized regimen selection protocols",
      "icon": "document"
    },
    {
      "text": "Establish monthly case review for regimen optimization",
      "icon": "clipboard"
    }
  ],
  "suggestions": [
    {
      "text": "Share provider-specific financial and clinical outcomes data",
      "icon": "chart-line"
    },
    {
      "text": "Analyze factors driving provider regimen selection decisions",
      "icon": "document"
    }
  ],
  "drilldowns": [
    {
      "label": "View by Payer Type",
      "cohort": "Multiple Myeloma Regimen Selection by Payer",
      "jsonFile": "multiple-myeloma-by-payer.json",
      "drilldownLevel": 1
    },
    {
      "label": "Compare Sites",
      "cohort": "Multiple Myeloma Regimen Selection by Site",
      "jsonFile": "multiple-myeloma-by-site.json",
      "drilldownLevel": 1
    },
    {
      "label": "Variance by Regimen",
      "cohort": "Multiple Myeloma Regimen Margin Analysis",
      "jsonFile": "multiple-myeloma-regimen-margins.json",
      "drilldownLevel": 1
    }
  ]
} 